XML 14 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Restricted Stock Units (RSUs) [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Restricted Stock Units (RSUs) [Member]
Common Stock [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2015     110,500,514 1,578,962      
Balance at Dec. 31, 2015     $ 46,030 $ 2 $ 358 $ (49,832) $ (3,442)
Exchange of convertible preferred stock warrants to common stock (in shares)     10,807      
Exchange of convertible preferred stock warrants to common stock     25 25
Reclassification of convertible shareholder notes derivative liability     2,268 2,268
Conversion of convertible notes into common stock (in shares)     8,091,103      
Conversion of convertible notes into common stock     $ 8 12,148 12,156
Conversion of preferred stock into common stock (in shares)     (110,500,514) 9,208,376      
Conversion of preferred stock into common stock     $ (46,030) $ 9 46,021
Issuance of common stock upon reverse merger (in shares)     19,228,595      
Issuance of common stock upon reverse merger     $ 19 18,902 18,921
Exercise of stock options (in shares)     13,460      
Exercise of stock options     22 22
Share-based compensation     942 942
Net loss     (10,310) (10,310)
Balance (in shares) at Dec. 31, 2016     38,131,303      
Balance at Dec. 31, 2016     $ 38 80,686 (60,142) 20,582
Exercise of stock options (in shares)     87,357      
Exercise of stock options     144 144
Share-based compensation     2,707 2,707
Net loss     (12,308) (12,308)
Balance (in shares) at Dec. 31, 2017     4,246,519      
Balance at Dec. 31, 2017     $ 38 83,537 (72,450) 11,125
Exercise of stock options (in shares)       237      
Exercise of stock options       5 5
Share-based compensation       615 615
Net loss       (3,584) (3,584)
Adjustments to opening balance for change in accounting principle at Dec. 31, 2017     76 76
Restricted stock units vested and issued (in shares)       2,271      
Balance (in shares) at Mar. 31, 2018       4,249,027      
Balance at Mar. 31, 2018       $ 38 84,157 (75,988) 8,207
Balance (in shares) at Dec. 31, 2017     4,246,519      
Balance at Dec. 31, 2017     $ 38 83,537 (72,450) 11,125
Net loss             (10,345)
Adjustments to opening balance for change in accounting principle at Dec. 31, 2017     76 76
Balance (in shares) at Sep. 30, 2018       4,253,100      
Balance at Sep. 30, 2018       $ 38 85,625 (82,719) 2,944
Balance (in shares) at Dec. 31, 2017     4,246,519      
Balance at Dec. 31, 2017     $ 38 83,537 (72,450) $ 11,125
Exercise of stock options (in shares)     2,140     2,488
Exercise of stock options     $ 0 4 $ 4
Share-based compensation     2,774 2,774
Net loss     (13,987) (13,987)
Adjustments to opening balance for change in accounting principle at Dec. 31, 2017     76 76
Sale of common stock and warrants, net of issuance costs of $200     $ 5 3,795 3,800
Sale of common stock and warrants, net of issuance costs of $200 (in shares)       5,333,332      
Restricted stock units vested and issued (in shares) 57,108          
Balance (in shares) at Dec. 31, 2018     4,845,697      
Balance at Dec. 31, 2018     $ 43 90,110 (86,361) 3,792
Balance (in shares) at Mar. 31, 2018       4,249,027      
Balance at Mar. 31, 2018       $ 38 84,157 (75,988) 8,207
Share-based compensation       738 738
Net loss       (3,217) (3,217)
Restricted stock units vested and issued (in shares)       4,073      
Balance (in shares) at Jun. 30, 2018       4,253,100      
Balance at Jun. 30, 2018       $ 38 84,895 (79,175) 5,758
Share-based compensation       730 730
Net loss       (3,544) (3,544)
Balance (in shares) at Sep. 30, 2018       4,253,100      
Balance at Sep. 30, 2018       $ 38 85,625 (82,719) 2,944
Balance (in shares) at Dec. 31, 2018     4,845,697      
Balance at Dec. 31, 2018     $ 43 90,110 (86,361) 3,792
Share-based compensation       690 690
Net loss       (3,665) (3,665)
Restricted stock units vested and issued (in shares)       2,268      
Balance (in shares) at Mar. 31, 2019       4,847,965      
Balance at Mar. 31, 2019       $ 44 90,800 (90,026) 818
Balance (in shares) at Dec. 31, 2018     4,845,697      
Balance at Dec. 31, 2018     $ 43 90,110 (86,361) $ 3,792
Exercise of stock options (in shares)            
Net loss             $ (11,208)
Balance (in shares) at Sep. 30, 2019       6,825,183      
Balance at Sep. 30, 2019       $ 46 102,716 (97,568) 5,194
Balance (in shares) at Mar. 31, 2019       4,847,965      
Balance at Mar. 31, 2019       $ 44 90,800 (90,026) 818
Share-based compensation       696 696
Net loss       (3,750) (3,750)
Balance (in shares) at Jun. 30, 2019       4,847,471      
Balance at Jun. 30, 2019       $ 44 91,496 (93,776) (2,236)
Conversion of convertible notes into common stock (in shares)       210,887      
Conversion of convertible notes into common stock       1,206 1,206
Share-based compensation       756 756
Net loss       (3,792) (3,792)
Sale of common stock and warrants, net of issuance costs of $200       $ 2 9,258 9,260
Sale of common stock and warrants, net of issuance costs of $200 (in shares)       1,741,667      
Restricted stock units vested and issued (in shares)       25,158      
Balance (in shares) at Sep. 30, 2019       6,825,183      
Balance at Sep. 30, 2019       $ 46 $ 102,716 $ (97,568) $ 5,194